Androgen regulation of the human pseudoautosomal gene MIC2, a potential marker for prostate cancer

Molecular Carcinogenesis

Volumn 23, Issue 1, 1998, Pages 13-19

  Shen, Jiancheng ^a   Zhau, Haiyen E ^a,b   Hursting, Stephen D ^a   Chung, Leland W K ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Androgen; Differential display polymerase chain reaction; Marker; MIC2; Prostate cancer

Indexed keywords

ANDROGEN; BICALUTAMIDE; CUTINASE; GENE PRODUCT; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ANTIGEN EXPRESSION; ARTICLE; CANCER GENETICS; CANCER GROWTH; DOSE TIME EFFECT RELATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HORMONAL REGULATION; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METASTASIS POTENTIAL; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; SEQUENCE HOMOLOGY; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANDROGENS; ANTIGENS, CD; BASE SEQUENCE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL ADHESION MOLECULES; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; SEQUENCE HOMOLOGY, NUCLEIC ACID; TUMOR MARKERS, BIOLOGICAL;

EID: 0031710240     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199809)23:1<13::AID-MC2>3.0.CO;2-I     Document Type: Article

References (18)

1. Huggins C, Stevens RE, Hodges CV. Studies on prostatic cancer: The effect of castration on advanced carcinoma of the prostate gland. Arch Surg 43:209-223, 1941.
2. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257:967-971, 1992.
3. Horoszewicz JS, Leong SS, Kawinski E, et al. LNCaP model of human prostatic carcinoma. Cancer Res 43:1809-1918, 1983.
4. Wu HC, Hsieh JT, Gleave ME, Brown NM, Pathak S, Chung LWK. Derivation of androgen-independent human LNCaP prostatic sublines: Role of bone stromal cells. Int J Cancer 57:406-412, 1994.
5. Thalmann GN, Anezinis PE, Chang S-M, et al. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 54:2577-2581, 1994.
6. Zhau HE, Chang S-M, Chen B-Q, et al. Androgen-repressed phenotype in human prostate cancer. Proc Natl Acad Sci USA 93:15152-15157, 1996.
7. Chomcyzynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-169, 1987.
8. Goodfellow PJ, Darling SM, Thomas NS, Goodfellow PN. A pseudoautosomal gene in man. Science 234:740-743, 1986.
9. Levy R, Dilley J, Fox RI, Warnke R. A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies. Proc Natl Acad Sci USA 76:6552-6556, 1979.
10. Goodfellow PN, Banting R, Sheer D, et al. Genetic evidence that a Y-linked gene in men is homologous to a gene on the X chromosome. Nature 302:346-349, 1983.
11. Gelin C, Aubrit F, Phalipon A, et al. The E2 antigen, a 32 kd glycoprotein involved in T-cell adhesion processes, is the MIC2 gene product. EMBO J 8:3253-3259, 1989.
12. Hamilton G, Fellinger EJ, Schratter I, Fritsch A. Characterization of a human endocrine tissue and tumor-associated Ewing's sarcoma antigen. Cancer Res 48:6127-6134, 1988.
13. Ambros IM, Ambros PF, Strehl S, Kovar H, Gadner H, Salzer-Kuntschik M. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Cancer 67:1886-1893, 1991.
14. Perman EJ, Dickman PS, Askin FB, Grier HE, Miser JS, Link MP. Ewing's sarcoma - Routine diagnostic utilization of MIC2 analysis: A Pediatric Oncology Group/Children's Cancer Group intergroup study. Hum Pathol 25:304-307, 1994.
15. Fellinger EJ, Garin-chesa P, Triche TJ, Huvos AG, Rettig WJ. Immunohistochemical analysis of Ewing's sarcoma cell surface antigen p30/32MIC2. Am J Pathol 139:317-325, 1991.
16. Allhoff EP, Proppe KH, Chapman CM, Lin C-W, Proud Jr. GR. Evaluation of prostatic acid phosphatase and prostate specific antigen in identification of prostatic cancer. J Urol 129:315-323, 1983.
17. Chung LWK, Chang SM, Bel C, Zhau HYE, Ro JY, von Eschenbach AC. Prostatic carcinogenesis evoked by cellular interaction. Environ Health Perspect 77:23-28, 1989.
18. Costanza ME, Nathanson L. Carcinofetal antigens. Progress in Clinical Immunology 2:191-224, 1974.